STANKOVICH THOMAS — SEC Form 4 filings
SEC reporting owner CIK 1181166. 1 Form 4 filing on record with FilingPulse; latest filed 2024-08-13.
Transaction summary — filings shown
Covers all 1 filing on record, filed 2024-08-13 to 2024-08-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 1 filing — 172 shares, $39 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: sale of 48 shares @ $0.25 ($12) in ReShape Lifesciences Inc., filed 2024-08-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ReShape Lifesciences Inc. (RSLS) | Chief Financial Officer | 1 | — | 4 legs · 172 sh · $39 | — |
Form 4 filings — STANKOVICH THOMAS
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-08-13 | 4 | ReShape Lifesciences Inc. (RSLS) | Sale (S): 39 @ $0.23 · Sale (S): 42 @ $0.25 · Sale (S): 43 @ $0.17 · Sale (S): 48 @ $0.25 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1181166 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →